Global Analysis of Small Molecule Binding to Related Protein Targets

被引:33
作者
Kruger, Felix A. [1 ]
Overington, John P. [1 ]
机构
[1] European Bioinformat Inst, Hinxton, England
基金
英国惠康基金; 英国工程与自然科学研究理事会;
关键词
H-3 RECEPTOR ANTAGONISTS; RAT; PHARMACOLOGY; PROMISCUITY; DISCOVERY; ORTHOLOGS; DATABASE; POTENCY; MODELS;
D O I
10.1371/journal.pcbi.1002333
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We report on the integration of pharmacological data and homology information for a large scale analysis of small molecule binding to related targets. Differences in small molecule binding have been assessed for curated pairs of human to rat orthologs and also for recently diverged human paralogs. Our analysis shows that in general, small molecule binding is conserved for pairs of human to rat orthologs. Using statistical tests, we identified a small number of cases where small molecule binding is different between human and rat, some of which had previously been reported in the literature. Knowledge of species specific pharmacology can be advantageous for drug discovery, where rats are frequently used as a model system. For human paralogs, we demonstrate a global correlation between sequence identity and the binding of small molecules with equivalent affinity. Our findings provide an initial general model relating small molecule binding and sequence divergence, containing the foundations for a general model to anticipate and predict within-target-family selectivity.
引用
收藏
页数:9
相关论文
共 52 条
  • [11] Davis AM, 1999, ANGEW CHEM INT EDIT, V38, P737, DOI 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO
  • [12] 2-R
  • [13] Structural basis for ligand promiscuity in cytochrome P450 3A4
    Ekroos, Marika
    Sjogren, Tove
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (37) : 13682 - 13687
  • [14] Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]:: I.: Potent and selective histamine H3 receptor antagonist with drug-like properties
    Esbenshade, TA
    Fox, GB
    Krueger, KM
    Miller, TR
    Kang, CH
    Denny, LI
    Witte, DG
    Yao, BB
    Pan, LP
    Wetter, J
    Marsh, K
    Bennani, YL
    Cowart, MD
    Sullivan, JP
    Hancock, AA
    Esbenshade, T
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01) : 165 - 175
  • [15] A small molecule-kinase interaction map for clinical kinase inhibitors
    Fabian, MA
    Biggs, WH
    Treiber, DK
    Atteridge, CE
    Azimioara, MD
    Benedetti, MG
    Carter, TA
    Ciceri, P
    Edeen, PT
    Floyd, M
    Ford, JM
    Galvin, M
    Gerlach, JL
    Grotzfeld, RM
    Herrgard, S
    Insko, DE
    Insko, MA
    Lai, AG
    Lélias, JM
    Mehta, SA
    Milanov, ZV
    Velasco, AM
    Wodicka, LM
    Patel, HK
    Zarrinkar, PP
    Lockhart, DJ
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (03) : 329 - 336
  • [16] The Pfam protein families database
    Finn, Robert D.
    Mistry, Jaina
    Tate, John
    Coggill, Penny
    Heger, Andreas
    Pollington, Joanne E.
    Gavin, O. Luke
    Gunasekaran, Prasad
    Ceric, Goran
    Forslund, Kristoffer
    Holm, Liisa
    Sonnhammer, Erik L. L.
    Eddy, Sean R.
    Bateman, Alex
    [J]. NUCLEIC ACIDS RESEARCH, 2010, 38 : D211 - D222
  • [17] DISTINGUISHING HOMOLOGOUS FROM ANALOGOUS PROTEINS
    FITCH, WM
    [J]. SYSTEMATIC ZOOLOGY, 1970, 19 (02): : 99 - &
  • [18] Fox J, 2011, An {R} companion to applied regression, Vsecond
  • [19] CLINICAL-PHARMACOLOGY - DRUG DEVELOPMENT
    GEORGE, CF
    [J]. BRITISH MEDICAL JOURNAL, 1980, 281 (6252) : 1397 - 1399
  • [20] Probing the links between in vitro potency, ADMET and physicochemical parameters
    Gleeson, M. Paul
    Hersey, Anne
    Montanari, Dino
    Overington, John
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (03) : 197 - 208